Warren Remedies Profile
Key Indicators
- Authorised Capital ₹ 30.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 15.00 Cr
as on 16-11-2024
- Company Age 2 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 239.00 Cr
as on 16-11-2024
About Warren Remedies
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 30.00 Cr and a paid-up capital of Rs 15.00 Cr.
The company currently has active open charges totaling ₹239.00 Cr.
The Key Managerial Personnel (KMP) at Warren Remedies Private Limited India is Jayshanker Menon as COMPANY SECRETARY. Sundeep Bambolkar, Ulhas Joshi, and Aditi Panandikar serve as directors at the Company.
- CIN/LLPIN
U24304MH2022PTC384184
- Company No.
384184
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Jun 2022
- Date of AGM
24 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Aurangabad, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Warren Remedies?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jayshanker Menon  | Company Secretary | 01-Dec-2022 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ulhas Joshi | Additional Director | 24-Apr-2024 | Current |
| Sundeep Bambolkar | Director | 07-Jun-2022 | Current |
| Aditi Panandikar | Director | 07-Jun-2022 | Current |
Financial Performance and Corporate Structure Insights of Warren Remedies.
Warren Remedies Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Warren Remedies?
In 2023, Warren Remedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Xtend Industrial Designers And Engineers Private LimitedActive 29 years 9 monthsSundeep Bambolkar and Aditi Panandikar are mutual person
Indoco Remedies LimitedActive 77 years 3 monthsSundeep Bambolkar and Aditi Panandikar are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 09 Jul 2024 | ₹25.00 Cr | Open |
Hdfc Bank Limited Creation Date: 08 Jul 2024 | ₹125.00 Cr | Open |
Standard Chartered Bank Creation Date: 19 Oct 2023 | ₹89.00 Cr | Open |
How Many Employees Work at Warren Remedies?
Unlock and access historical data on people associated with Warren Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Warren Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Warren Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
